Table 1. Characteristics of the 702 participants.
| Variable | All participants (n = 702) | No prior infection | Prior infection | |||
|---|---|---|---|---|---|---|
| Unvaccinated | Vaccinated | Unvaccinated | Vaccinated | p-value1 | ||
| (n = 212) | (n = 342) | (109) | (n = 39) | |||
| Age, median (IQR) | 43 (33–59) | 38 (30–51) | 49 (36–63) | 40 (31–55) | 45 (33–58) | <0.0001 |
| Age Range | ||||||
| 18–45, n (%) | 385 (54.8) | 140 (66.0) | 158 (46.2) | 66 (60.6) | 21 (53.8) | <0.0001 |
| 46–65, n (%) | 222 (31.7) | 58 (27.4) | 114 (33.3) | 35 (32.1) | 15 (38.5) | |
| >66, n (%) | 95 (13.5) | 14 (6.6) | 70 (20.5) | 8 (7.3) | 3 (7.7) | |
| Gender | ||||||
| Male, n (%) | 332 (47.3) | 102 (48.1) | 160 (46.8) | 48 (44.0) | 22 (56.4) | >0.05 |
| Female, n (%) | 370 (52.7) | 110 (51.9) | 182 (53.2) | 61 (56.0) | 17 (43.6) | |
Data are presented as median (IQR) or n (%)
1 Difference among all types. Differences in measurement data among the four groups were compared with the Kruskal Wallis test followed by Dunn’s multiple comparisons test or Chi-squared test